Research Areas

Accuracy and User Performance Evaluation of the Modified Investigational Blood Glucose Test Strip for Alternative Site Capillary Blood Testing (included 9 subjects with blood glucose under 75 mg/dL)

An Investigational Blood Glucose Monitoring System: Comparison of Lay User and Professional Glucose Results to a Validated Method

Accuracy and User Performance Evaluation of A Modified Investigational Blood Glucose Test Strip for Finger and Alternative Site Capillary Blood Testing

A User Study Protocol: Protocol for User Evaluation of the Performance of An Investigational Blood Glucose Monitoring System

An Investigational Glucose Test Strip with An Investigational Glucose Meter Alternative Site Capillary Evaluation Patient vs. Technician.

A Clinical Evaluation – Lay User and Professional Comparison to a Validated Method, Instructions for Use, Human Factors, and Marketing Claims Study

An Investigational Test Strip with An Investigational Glucose Monitoring System Alternative Site Capillary Evaluation

An Investigational Glucose Monitoring System with An Investigational Test Strip Alternative Site Capillary Evaluation

A Regulatory Clinical Evaluation – Lay User and Professional Comparison to a Validated Method and Instructions for Use Evaluation

An In-Clinic, Randomized, Cross-Over Study to Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in An Investigational Insulin Pump System with Hypoglycemic Induction from Exercise. (AP)

A Randomized, Phase 3, Open‐Label Trial Comparing the Effect of the Addition of An Investigational Medication Once Weekly versus Insulin Lispro (U100) Three Times Daily in Participants with Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) with or without Metformin

A 78-week Trial comparing the effect and safety of an investigational once weekly insulin and once daily insulin glargine 100 units/mL, both in combination with noninsulin anti-diabetic treatment, in insulin naïve Subjects with type 2 diabetes. ONWARDS 1

A Double-Blinded, Placebo-controlled, Double Dummy, Multicenter Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of An Investigational Medication in Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on One, Two or Three Oral Glucose-lowering Agents.

A 26-Week Double Blinded, Multiregional, Trial Comparing the Effect and Safety of A Once Weekly Insulin and Once Daily Marketed Insulin 100 units/mL, Both in Combination with Non-Insulin Anti-Diabetic Drugs In Inulin Naïve Subjects with Type 2 Diabetes

A Phase 2 Study of Once-Weekly Investigational Compound Compared with Placebo and Dulaglutide in Participants with Type 2 Diabetes Mellitus

A Phase 1b, Randomized, Single-blind, Placebo-controlled, Multiple Ascending Dose (MAD) Study to Assess the Steady-State Pharmacokinetics and DQ8 Blocking Efficacy of Orally Administered Investigational Medication in Patients with Type 1 Diabetes and HLA-DQ8

Efficacy and Safety of A Once Weekly Insulin Compared to Once Daily Marketing Insulin 100 units/mL, Both in Combination with Insulin Aspart, In Adults with Type I Diabetes

Effect of Renal Impairment on Pharmacodynamics and Pharmokinetics: A Multiple-Center, Open-Label, Parallel Group Study Following Single Oral Dosing of An Investigational Medication to Type 2 Diabetes Patients with Varying Degrees of Renal Impairment

Efficacy and Safety of An Investigational Drug Administered Once Weekly in Participants with Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double Blind, Placebo Controlled Trial

Efficacy and Safety of An Investigational Drug Adminisered Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants without Type 2 Diabetes Who Have Obesity or Are Overweight with Weight Related Comorbidities: A Randomized, Double Blind, Placebo Controlled Trial